CIK 0001176309
- Non-accelerated filer
- Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980376008
- Phone
- +1 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-06-06 | REGALS CAPITAL MANAGEMENT LP 10% owner | Purchase | +2,252 | $4.44 | $10K | 1,453,637 |
| 2014-04-14 | JACOB HAROLD Director | Purchase | +700 | $14.41 | $10K | 700 |
| 2014-04-09 | KIDRON NADAV President and CEO | Grant or award · Stock Option (right to buy) | +47,134 | 47,134 | ||
| 2014-04-09 | Berelowitz Michael Director | Grant or award · Stock Option (right to buy) | +13,094 | 13,094 | ||
| 2014-04-09 | Kidron Miriam Chief Technology Officer | Grant or award · Stock Option (right to buy) | +47,134 | 47,134 | ||
| 2014-04-09 | Sank Leonard Director | Grant or award · Stock Option (right to buy) | +13,094 | 13,094 | ||
| 2014-04-09 | JACOB HAROLD Director | Grant or award · Stock Option (right to buy) | +13,094 | 13,094 | ||
| 2014-04-09 | OSTROV GERALD M Director | Grant or award · Stock Option (right to buy) | +13,094 | 13,094 | ||
| 2014-04-01 | Kidron Miriam Chief Technology Officer | Exercise or conversion | +137,300 | $0.01 | $2K | 137,300 |
| 2014-04-01 | Kidron Miriam Chief Technology Officer | Sale | −137,300 | $12.03 | $1.7M | 0 |
| 2014-04-01 | Kidron Miriam Chief Technology Officer | Exercise or conversion · Warrant (right to buy) | −137,300 | 142,814 | ||
| 2014-03-31 | Berelowitz Michael Director | Exercise or conversion | +3,334 | $4.08 | $14K | 3,334 |
| 2014-03-31 | Berelowitz Michael Director | Exercise or conversion | +6,100 | $5.76 | $35K | 9,434 |
| 2014-03-31 | Berelowitz Michael Director | Sale | −9,434 | $10.50 | $99K | 0 |
| 2014-03-31 | Berelowitz Michael Director | Exercise or conversion · Stock Option (right to buy) | −3,334 | 0 | ||
| 2014-03-31 | Berelowitz Michael Director | Exercise or conversion · Stock Option (right to buy) | −6,100 | 18,900 | ||
| 2014-03-25 | REGALS CAPITAL MANAGEMENT LP 10% owner | Purchase | +47,300 | $10.90 | $516K | 1,451,385 |
| 2014-03-24 | REGALS CAPITAL MANAGEMENT LP 10% owner | Purchase | +27,700 | $10.15 | $281K | 1,404,085 |
| 2014-02-06 | REGALS CAPITAL MANAGEMENT LP 10% owner | Purchase | +26,800 | $14.96 | $401K | 1,376,385 |
| 2014-02-05 | REGALS CAPITAL MANAGEMENT LP 10% owner | Purchase | +24,492 | $16.32 | $400K | 1,349,585 |
Page 19 of 22 · 437 trades